BRAF and neoplasm: Figure 2 visually represents the personalized therapy pathways for BRAF-mutant melanoma, while Table 1 provides a summary of these approaches, including tumor-infiltrating lymphocyte (TIL) therapy, T-cell therapy, biomarker detection, targeted therapy, and neoantigen-based strategies.